全文获取类型
收费全文 | 16007篇 |
免费 | 924篇 |
国内免费 | 113篇 |
专业分类
耳鼻咽喉 | 135篇 |
儿科学 | 324篇 |
妇产科学 | 175篇 |
基础医学 | 2001篇 |
口腔科学 | 447篇 |
临床医学 | 1093篇 |
内科学 | 4488篇 |
皮肤病学 | 459篇 |
神经病学 | 869篇 |
特种医学 | 617篇 |
外科学 | 2733篇 |
综合类 | 58篇 |
一般理论 | 1篇 |
预防医学 | 409篇 |
眼科学 | 206篇 |
药学 | 986篇 |
中国医学 | 19篇 |
肿瘤学 | 2024篇 |
出版年
2023年 | 181篇 |
2022年 | 372篇 |
2021年 | 573篇 |
2020年 | 285篇 |
2019年 | 404篇 |
2018年 | 492篇 |
2017年 | 429篇 |
2016年 | 462篇 |
2015年 | 451篇 |
2014年 | 580篇 |
2013年 | 621篇 |
2012年 | 1051篇 |
2011年 | 1096篇 |
2010年 | 575篇 |
2009年 | 487篇 |
2008年 | 825篇 |
2007年 | 906篇 |
2006年 | 774篇 |
2005年 | 786篇 |
2004年 | 685篇 |
2003年 | 592篇 |
2002年 | 541篇 |
2001年 | 332篇 |
2000年 | 291篇 |
1999年 | 273篇 |
1998年 | 132篇 |
1997年 | 98篇 |
1996年 | 98篇 |
1995年 | 81篇 |
1994年 | 75篇 |
1993年 | 80篇 |
1992年 | 250篇 |
1991年 | 226篇 |
1990年 | 208篇 |
1989年 | 216篇 |
1988年 | 171篇 |
1987年 | 165篇 |
1986年 | 174篇 |
1985年 | 125篇 |
1984年 | 98篇 |
1983年 | 97篇 |
1982年 | 52篇 |
1979年 | 65篇 |
1978年 | 54篇 |
1977年 | 46篇 |
1975年 | 40篇 |
1974年 | 50篇 |
1973年 | 50篇 |
1972年 | 45篇 |
1971年 | 40篇 |
排序方式: 共有10000条查询结果,搜索用时 10 毫秒
91.
Tsutomu Imai MD Akiko Horiuchi MD Tanri Shiozawa MD Ryosuke Osada MD Norihiko Kikuchi MD Satoshi Ohira MD Kenji Oka MD Ikuo Konishi MD 《Human pathology》2004,35(12):2067
E-cadherin and catenins play key roles in cell adhesion and motility. Little is known about the changes in expression of these molecules in the progression of ovarian carcinomas. In the present study, the immunohistochemical expression of E-cadherin and α-, β-, and γ-catenins was examined in 77 cases of ovarian carcinoma. In addition, the expression of these molecules was evaluated in 26 matched pairs of primary and metastatic lesions of advanced ovarian carcinomas. Of the 77 primary lesions, positive staining for E-cadherin and α-, β-, and γ-catenin was observed in 75 (97%), 63 (82%), 71 (92%) and 57 (74%) cases, respectively. Positivity for E-cadherin and α-, β-, and γ-catenin was significantly decreased in stage III and IV tumors compared with stage I and II tumors, suggesting that expression of the cadherin-catenin complex is reduced with the advancing stages of a tumor. Interestingly, expression of E-cadherin and α-, β-, and γ-catenin in the lesions of peritoneal dissemination was significantly increased compared with the primary lesions. These findings suggest that expression of the cadherin-catenin complex changes markedly and that reexpression may occur during the peritoneal dissemination of ovarian carcinoma cells. 相似文献
92.
Tsukamoto K Suzuki H Harada D Namba A Abe S Usami S 《European journal of human genetics : EJHG》2003,11(12):916-922
Molecular diagnosis makes a substantial contribution to precise diagnosis, subclassification, prognosis, and selection of therapy. Mutations in the PDS (SLC26A4) gene are known to be responsible for both Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct, and the molecular confirmation of the PDS gene has become important in the diagnosis of these conditions. In the present study, PDS mutation analysis confirmed that PDS mutations were present and significantly responsible in 90% of Pendred families, and in 78.1% of families with nonsyndromic hearing loss associated with enlarged vestibular aqueduct. Furthermore, variable phenotypic expression by the same combination of mutations indicated that these two conditions are part of a continuous category of disease. Interestingly, the PDS mutation spectrum in Japanese, including the seven novel mutations revealed by this study, is very different from that found in Caucasians. Of the novel mutations detected, 53% were the H723R mutation, suggesting a possible founder effect. Ethnic background is therefore presumably important and should be noted when genetic testing is being performed. The PDS gene mutation spectrum in Japanese may be representative of those in Eastern Asian populations and its elucidation is expected to facilitate the molecular diagnosis of a variety of diseases. 相似文献
93.
Wang C Horiuchi A Imai T Ohira S Itoh K Nikaido T Katsuyama Y Konishi I 《The Journal of pathology》2004,202(2):215-223
BRCA1 is a putative tumour suppressor gene responsible for a hereditary ovarian cancer syndrome. To clarify the possible involvement of BRCA1 in the development of sporadic ovarian neoplasms, this study analysed the immunohistochemical expression of BRCA1 protein in normal ovarian surface epithelium and 119 epithelial ovarian tumours (19 benign, 24 borderline, and 76 malignant tumours). Loss of heterozygosity (LOH) of BRCA1 was examined using three microsatellite markers to analyse the relationship between BRCA1 expression and alterations of the BRCA1 gene. Methylation of the BRCA1 promoter was also analysed by methylation-specific PCR. In ovarian carcinomas showing heterogeneous expression of BRCA1 protein in the same tumour, LOH and methylation status were analysed using microdissection techniques. Finally, the relationship of BRCA1 expression or its genetic alteration to clinicopathological parameters and patient survival was analysed. Ovarian surface epithelial cells expressed BRCA1 protein. Decreased expression of BRCA1 was found in 16% of benign tumours, 38% of borderline tumours, and 72% of carcinomas. LOH of BRCA1 was demonstrated in no benign tumours, 15% of borderline tumours, and 66% of carcinomas. Methylation of BRCA1 was not detected in benign or borderline tumours, but was present in 31% of carcinomas. Reduced expression of BRCA1 correlated with the presence of gene methylation. The frequency of BRCA1 methylation and LOH was higher in serous carcinomas than in other types. In one of the three serous carcinomas that showed heterogeneous expression of BRCA1, BRCA1-positive borderline-like tumour cells were LOH-positive and methylation-negative, whereas adjacent BRCA1-negative carcinoma cells were LOH-positive and methylation-positive. The prognosis of carcinoma patients did not correlate with BRCA1 expression or genetic status. These findings suggest that reduced expression of BRCA1 protein along with genetic and epigenetic changes of the BRCA1 gene play an important role in the development of sporadic ovarian carcinomas, particularly those of serous histology. 相似文献
94.
Imai T Tanaka Y Okamoto T Yamamoto Y Horinouchi T Tanaka H Koike K Shigenobu K 《Acta physiologica Scandinavica》2002,176(1):57-63
Urinary bladder smooth muscle (UBSM) exhibits spontaneous contraction. This spontaneous mechanical activity is myogenic and can be closely related to the UBSM cell action potential to facilitate Ca2+ influx through voltage-gated Ca2+ channels. In the present study, to know whether this membrane electrical event is the exclusive mechanism to trigger spontaneous smooth muscle contraction, we compared the inhibitory effects of Ca2+ channel blockers on the spontaneous action potential and mechanical activity in the isolated guinea-pig UBSM. Both action potential and rhythmic contraction were generated spontaneously in the presence of atropine (1 microM), phentolamine (1 microM), propranolol (1 microM), suramin (10 microM) and tetrodotoxin (1 microM), which suggest that both phenomena were myogenic in origin. Nisoldipine (100 nM) and diltiazem (10 microM) completely eliminated the generation of action potential whereas its frequency was dramatically increased by a dihydropyridine Ca2+ agonist, BayK 8644 (1 microM). In contrast to disappearance of action potential in the presence of Ca2+ channel blockers, spontaneous contraction of UBSM was inhibited only partly by nisoldipine or diltiazem and most of the mechanical components persisted in these channel blockers. These results indicate that spontaneous action potential in UBSM cell is generated through the activation of L-type voltage-gated Ca2+ channels. The subsequent elevation of intracellular Ca2+ concentrations during a burst of action potentials can be partly responsible for the induction of UBSM mechanical activity. In addition, the present study provides evidence that UBSM spontaneous mechanical activity is also attributable to the mechanism(s) other than the generation of Ca2+ spike. 相似文献
95.
Yoshida R; Nagira M; Imai T; Baba M; Takagi S; Tabira Y; Akagi J; Nomiyama H; Yoshie O 《International immunology》1998,10(7):901-910
EBI1-ligand chemokine (ELC) is a CC chemokine constitutively expressed in
various lymphoid tissues and a high-affinity functional ligand for
EBI1/CCR7, a seven transmembrane G-protein-coupled receptor originally
identified as an Epstein-Barr virus (EBV)-inducible gene. Here we examined
chemotactic activity of ELC on peripheral blood leukocytes. ELC attracted
both CD4+ and CD8+ T cells, particularly efficiently after activation with
IL-2 or with phytohemagglutinin (PHA) plus IL-2, as well as CD19+ B cells,
but not CD16+ NK cells, CD14+ monocytes or neutrophils. Among CD3+ T cells,
ELC attracted both CD45RO- naive and CD45RO+ memory subsets. ELC also
induced vigorous calcium mobilization in T cells stimulated with IL-2 with
an ED50 of 3 nM. ELC fused with the secreted form of alkaline phosphatase
(ELC-SEAP) specifically bound to lymphocytes and this binding was blocked
only by ELC among 10 CC chemokines so far tested. Notably, lymphocytes
stimulated with IL-2 or T cells expanded by PHA plus IL-2 showed much
higher levels of binding than fresh lymphocytes. Consistently, CCR7 mRNA
was detected in CD4+ and CD8+ T cells as well as B cells, but not in NK
cells, monocytes or neutrophils, and was dramatically increased in T cells
upon treatment with IL-2 or with PHA plus IL-2. Like ELC mRNA, CCR7 mRNA
was expressed in various lymphoid tissues. By in situ hybridization, ELC
and CCR7 mRNA were detected in the parafollicular and inner cortical
regions of a lymph node, and in the parafollicular regions of an appendix.
Collectively, ELC and CCR7 may be involved in the trafficking of a broad
spectrum of lymphocytes, especially activated T cells, into and within
various lymphoid tissues.
相似文献
96.
K Imai N Yuasa H Iwakiri K Nakamura H Hihara T Ishita A Inamoto I Okamoto K Ohta M Maeda 《Avian pathology》1992,21(1):119-126
Pathogenicity of two isolates of Marek's disease virus (MDV), MS1 and MS2, from chickens was examined in two genetically different strains of chickens, MD-susceptible P-2 chickens and less susceptible PDL-1 chickens. The isolates induced an early mortality syndrome unassociated with lymphoproliferative lesions in P-2 chickens. There were no significant differences in pathogenicity between our isolates and the Md/5 strain of very virulent MDV (vvMDV) in both P-2 and PDL-1 chickens. Protective indices of turkey herpes virus (HVT) vaccine against challenge with MS1 or MS2 in P-2 chickens were 54% and 28%, respectively, whereas HVT gave more than 80% protection in PDL-1 chickens. These results indicate that the two isolates could be classified as vvMDV. In contrast, a bivalent vaccine composed of HVT and serotype 2 MDV, and CVI988 vaccine gave good protection against challenge with the isolates in P-2 chickens; however, the best protection was given by the CBI988 vaccine. This is the first report of isolation of vvMDV in Japan. 相似文献
97.
Keiko Wakui Toshiro Nishida Jun-ichiro Masuda Takeshi Itoh Daisuke Katsumata Tsutomu Ohno Yoshimitsu Fukushima 《Journal of human genetics》1991,36(2):149-153
We report a malformed female infant withde novo interstitial deletion of 4q[46,XX,del(4)(q27q28.2)]. The MN blood type analysis of the family members showed that the patient had an intact blood group-MN locus. The locus of the gene responsible for the MN antigen activity is confined to a 4q28.2–4q31.1 segment on the basis of the result of this patient and the previous mapping data. 相似文献
98.
Tanabe A Tsuiki M Watanabe D Takagi S Takano K Naruse M 《Rinsho byori. The Japanese journal of clinical pathology》2004,52(8):704-710
Aldosterone is one the representative cardiovascular hormones involved in the blood pressure and body-fluid homeostasis. Elevation of aldosterone leads to systemic hypertension through its action on the mineralocorticoid receptor (MR) in the kidney. More recent studies demonstrated that aldosterone may produce target organ damage through its direct actions on the non-epithelial MR of the heart in addition to its systemic effects. Clinical experience in primary aldosteronism supports the concept that aldosterone is a risk factor of cardiovascular complications, since concentric type of cardiac hypertrophy is most common in primary aldosteronism among various types of endocrine hypertension. Clinical mega-trial in congestive heart failure (RALES study, EPHESUS study) demonstrated blocking angiotensin II action is not sufficient for cardioprotection unless aldosterone action is equally blocked. An important phenomenon related to this issue is the aldosterone breakthrough which implies a reelevation of plasma aldosterone during chronic administration of ACE inhibitors and Angiotensin receptor antagonists. Normal level of aldosterone could still be a risk factor. Combination of ACE inhibitor or ARB with aldosterone antagonist could result in a better cardioprotection in cardiovascular diseases. Although spironolactone has been the only one aldosterone antagonist, a new antagonist eplerenone has been developed. Eplerenone is specific to MR and is practically devoid of the major side effect gynecomastia of spironolactone. Another topic of aldosterone is its very quick cardiovascular effect presumably via a non-genomic action. All these recent findings support that this adrenocortical steroid hormone is as important as angiotensin II. Determining aldosterone levels is therefore much morel important than before in the diagnosis and treatment of cardiovascular diseases. 相似文献
99.
Karine Bollérot Daisuke Sugiyama Virginie Escriou Rodolphe Gautier Samuel Tozer Daniel Scherman Thierry Jaffredo 《Developmental dynamics》2006,235(1):105-114
We report here a method that allows fast, efficient, and low-cost screening for gene function in the vascular system of the vertebrate embryo. Through intracardiac delivery of nucleic acids optimally compacted by a specific cationic lipid, we are able to induce in vivo endothelial cell-specific gain-of-function during development of the vascular network in the chick embryo. When the nucleic acids are delivered during the period of intraembryonic hematopoiesis, aortic hemangioblasts, the forerunners of the hematopoietic stem cells known to derive from the aortic endothelium, are also labeled. Similarly, we show that siRNA could be used to induce loss-of-function in vascular endothelial cells. This gene transfer technique was also applied to the mouse embryo with a high efficiency. The present method allows large-scale analysis and may represent a new and versatile tool for functional genomics. 相似文献
100.
Watanabe M Shin'oka T Tohyama S Hibino N Konuma T Matsumura G Kosaka Y Ishida T Imai Y Yamakawa M Ikada Y Morita S 《Tissue engineering》2001,7(4):429-439
Tissue-engineered vascular autografts (TEVAs) were made by seeding 4-6 x 10(6) of mixed cells obtained from femoral veins of mongrel dogs onto tube-shaped biodegradable polymer scaffolds composed of a polyglycolid acid (PGA) nonwoven fabric sheet and a copolymer of L-lactide and caprolactone (n = 4). After 7 days, the inferior vena cavas (IVCs) of the same dogs were replaced with TEVAs. After 3, 4, 5, and 6 months, angiographies were performed, and the dogs were sacrificed. The implanted TEVAs were examined both grossly and immunohistologically. The implanted TEVAs showed no evidence of stenosis or dilatation. No thrombus was found inside the TEVAs, even without any anticoagulation therapy. Remnants of the polymer scaffolds were not observed in all specimens, and the overall gross appearance similar to that of native IVCs. Immunohistological staining revealed the presence of factor VIII positive nucleated cells at the luminal surface of the TEVAs. In addition, lesions were observed where alpha-smooth muscle actin and desmin positive cells existed. Implanted TEVAs contained a sufficient amount of extracellular matrix, and showed neither occlusion nor aneurysmal formation. In addition, endothelial cells were found to line the luminal surface of each TEVA. These results strongly suggest that "ideal" venous grafts with antithrombogenicity can be produced. 相似文献